|
Following the continued buy-back scheme and the receipt of updated shares in issue information from Abbott Laboratories, (USA, Large Cap), resulting in a market capitalisation change greater than USD 2bn, FTSE announces the following changes:
| INDEX |
CHANGE |
EFFECTIVE FROM
START OF TRADING |
| FTSE All-World Index |
Abbott Laboratories (USA, 2002305) will remain in the index with a decreased shares in issue total of 1,501,938,538 and a unchanged investability weighting of 100%. |
21 May 2014 |
| FTSE Multinationals |
Abbott Laboratories will remain in the index as detailed above. |
21 May 2014 |
| FTSE Global Style Index |
Abbott Laboratories will remain in the index as detailed above. |
21 May 2014 |
| FTSE Global 100 Index |
Abbott Laboratories will remain in the index as detailed above. |
21 May 2014 |
For further information or general enquiries please contact us at info@ftse.com or call:
| Client Services in UK: |
Tel: +44 (0) 20 7866 1810 |
| Client Services in Europe, Middle East & Africa: |
Tel: +44 (0) 20 7866 1810 |
| Client Services in US: |
New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 |
| Client Services in Asia Pacific: |
Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 |
Alternatively please visit our website at www.ftse.com
|
